Retraction: CXCL5 Plays a Promoting Role in Osteosarcoma Cell Migration and Invasion in Autocrine- and Paracrine-Dependent Manners [0.03%]
撤稿：CXCL5通过自分泌和旁分泌的两种方式促进成骨细胞迁移和侵袭作用
Oncology Research Editorial Office
Oncology Research Editorial Office
[This retracts the article DOI: 10.3727/096504016X14732772150343.]. © 2026 The Author. Published by Tech Science Press.
Prognostic Value of Spatial and Topological Features of Tumor Microenvironment in Classic Hodgkin Lymphoma [0.03%]
经典霍奇金淋巴瘤中肿瘤微环境的空间和拓扑特征的预后价值
Irene Bernal-Florindo,Jose Angel Raposo-Puglia,Felix A Ruiz et al.
Irene Bernal-Florindo et al.
Classic Hodgkin lymphoma (CHL) constitutes a B-cell malignant lymphoid neoplasm derived from the germinal center. Despite current treatment protocols based on chemotherapy, radiotherapy, anti-cluster of differentiation (CD) 30 antibody-drug...
BCL2-Associated Transcription Factor 1 Promotes SRC/Hypoxia-Inducible Factor 1 Subunit α-Mediated Cancer Stemness in Radioresistant Triple-Negative Breast Cancer [0.03%]
BCL2相关转录因子1通过SRC/缺氧诱导因子1亚基α介导三阴性乳腺癌的放射抵抗性肿瘤干细胞特性促进作用
Yu-Hao Huang,Hao-Yeh Chen,Peng-Ju Chien et al.
Yu-Hao Huang et al.
Backgrounds: Triple-negative breast cancer (TNBC) is highly aggressive, insensitive to radiotherapy, and exhibits increased cancer stem cell (CSC) properties, contributing to poor patient outcomes. B-cell lymphoma 2 (BCL2) associated transc...
Dual Immune Checkpoint Blockade in Synchronous Hepatocellular and Renal Cell Carcinoma: A Real-World Case Report of Durable Dual Response [0.03%]
同步肝细胞癌和肾细胞癌的双重免疫检查点阻断：持续双重反应的病例报告
Piera Federico,Maria Anna Canciello,Barbara Granata et al.
Piera Federico et al.
Background: The synchronous occurrence of hepatocellular carcinoma (HCC) and clear cell renal cell carcinoma (ccRCC) is rare and poses significant therapeutic challenges, particularly in elderly patients with comorbidities. Although both ma...
Case Reports
Oncology research. 2026 Jun 16;34(7):30. DOI:10.32604/or.2026.078258 2026
PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer [0.03%]
Park2介导的PGK1降解抑制三阴性乳腺癌的部分上皮间质转化和转移
Zhengzheng Li,Haitong Xie,Yujuan Chen et al.
Zhengzheng Li et al.
Objectives: Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies. Phosphoglycerate kinase 1 (PGK1) drives TNBC progression, but mechanisms governing its protein stability remain unclear. This study aims t...
Impact of Germline BRCA1/2 Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan-An International CEBCC Study from Poland, the Czech Republic and Slovakia [0.03%]
BRCA1/2胚系突变对多西他赛耐药性转移性三阴性乳腺癌患者戈沙妥组单抗治疗临床疗效的影响——来自波兰、捷克和斯洛伐克的国际乳腺癌转化研究协作中心（CBTCS）的研究
Renata Pacholczak-Madej,Mirosława Püsküllüoğlu,Anna Polakiewicz-Gilowska et al.
Renata Pacholczak-Madej et al.
Background: Germline breast cancer susceptibility gene 1/2 (BRCA1/2) variants guide breast cancer treatment, but their clinical relevance in metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG) remains un...
Dysregulated Cell Signaling Pathways in Prostate Tumoral Plasticity-Checkpoints [0.03%]
前列腺肿瘤塑性调控失常的细胞信号通路检查点
Elena Matei,Ionuț Ciprian Iorga,Mariana Deacu et al.
Elena Matei et al.
Objectives: Deregulated plasticity is involved in initiation, progression, metastasis, and resistance to therapy of various cancers. Our study aimed to present new checkpoints involved in complex biological processes that sustain epithelial...
Orbital Metastases of Breast Cancer: Case Report and Review of the Literature [0.03%]
乳腺癌的转移性轨道病变：病例报告及文献复习
Teng Zhu,Siwen Zang,Bo Chen
Teng Zhu
Background: Orbital metastases are rare in breast cancer, representing only 3-10% of ocular metastases. This report highlights a case where orbital involvement was the first indicator of systemic metastatic spread. Case Presentation: A 72-y...
Case Reports
Oncology research. 2026 May 21;34(6):32. DOI:10.32604/or.2026.067876 2026
Phenotypic Response Surfaces-Guided Optimization (PRS-OPT) of Propolis-Metformin-Regorafenib Combination Therapy for MASLD-Associated Hepatocellular Carcinoma [0.03%]
用于MASLD相关肝细胞癌的蜂胶-二甲双胍-regorafenib联合治疗的表型反应面引导优化（PRS-OPT）
Yi-Sian Huang,Chung-Yung Ma,Hsiao-Yuh Roan et al.
Yi-Sian Huang et al.
Objectives: Hepatocellular carcinoma (HCC) arising in metabolic dysfunction-associated steatotic liver disease (MASLD) develops under lipid-rich stress and inflammatory remodeling, which can alter therapeutic windows. We aimed to determine ...
SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma [0.03%]
SFXN3可作为头颈鳞状细胞癌顺铂应答和生存预测生物标志物
Eun-Jeong Jeong,Yeon Soo Kim,Yujin Lee et al.
Eun-Jeong Jeong et al.
Objective: The systematic evaluation of expansive genomic databases facilitates the discovery of clinically vital biomarkers. While Sideroflexin 3 (SFXN3) consistently displays elevated expression in head and neck squamous cell carcinoma (H...